150 related articles for article (PubMed ID: 15958627)
41. Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer.
McFadyen MC; Cruickshank ME; Miller ID; McLeod HL; Melvin WT; Haites NE; Parkin D; Murray GI
Br J Cancer; 2001 Jul; 85(2):242-6. PubMed ID: 11461084
[TBL] [Abstract][Full Text] [Related]
42. Development of optimized cryptic peptides for immunotherapy.
Menez-Jamet J; Kosmatopoulos K
IDrugs; 2009 Feb; 12(2):98-102. PubMed ID: 19204883
[TBL] [Abstract][Full Text] [Related]
43. Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine.
van der Burg SH; Menon AG; Redeker A; Bonnet MC; Drijfhout JW; Tollenaar RA; van de Velde CJ; Moingeon P; Kuppen PJ; Offringa R; Melief CJ
Clin Cancer Res; 2002 May; 8(5):1019-27. PubMed ID: 12006514
[TBL] [Abstract][Full Text] [Related]
44. Cancer immunotherapy using tumor cryoablation.
Sidana A
Immunotherapy; 2014; 6(1):85-93. PubMed ID: 24341887
[TBL] [Abstract][Full Text] [Related]
45. Nutrition and the prevention and treatment of cancer: association of cytochrome P450 CYP1B1 with the role of fruit and fruit extracts.
Ware WR
Integr Cancer Ther; 2009 Mar; 8(1):22-8. PubMed ID: 19116217
[TBL] [Abstract][Full Text] [Related]
46. Experiments in immunity in cancer.
MURRAY G
Can Med Assoc J; 1958 Aug; 79(4):249-59. PubMed ID: 13573269
[No Abstract] [Full Text] [Related]
47. Cancer and immunity: who is shaping whom?
Kumar H
Int Rev Immunol; 2021; 40(5):317-318. PubMed ID: 34284699
[No Abstract] [Full Text] [Related]
48. Exploring a specialized programmed-cell death patterns to predict the prognosis and sensitivity of immunotherapy in cutaneous melanoma via machine learning.
Xiao L; He R; Hu K; Song G; Han S; Lin J; Chen Y; Zhang D; Wang W; Peng Y; Zhang J; Yu P
Apoptosis; 2024 Apr; ():. PubMed ID: 38615305
[TBL] [Abstract][Full Text] [Related]
49. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.
Shebbo S; Binothman N; Darwaish M; Niaz HA; Abdulal RH; Borjac J; Hashem AM; Mahmoud AB
Front Immunol; 2024; 15():1350208. PubMed ID: 38533510
[TBL] [Abstract][Full Text] [Related]
50. Lower overall survival in male patients with advanced disease undergoing allogeneic hematopoietic stem cell transplantation is associated with
Stute N; Koldehoff M
Haematologica; 2024 Mar; 109(3):799-808. PubMed ID: 37767566
[TBL] [Abstract][Full Text] [Related]
51. Vaccinating against cancer: getting to prime time.
Chang R; Gulley JL; Fong L
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37286302
[TBL] [Abstract][Full Text] [Related]
52. CYP1B1 inhibits ferroptosis and induces anti-PD-1 resistance by degrading ACSL4 in colorectal cancer.
Chen C; Yang Y; Guo Y; He J; Chen Z; Qiu S; Zhang Y; Ding H; Pan J; Pan Y
Cell Death Dis; 2023 Apr; 14(4):271. PubMed ID: 37059712
[TBL] [Abstract][Full Text] [Related]
53. Tumor Microenvironment and Metabolism: Role of the Mitochondrial Melatonergic Pathway in Determining Intercellular Interactions in a New Dynamic Homeostasis.
Anderson G
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613754
[TBL] [Abstract][Full Text] [Related]
54. CYP1B1: A Novel Molecular Biomarker Predicts Molecular Subtype, Tumor Microenvironment, and Immune Response in 33 Cancers.
Yuan B; Liu G; Dai Z; Wang L; Lin B; Zhang J
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428734
[TBL] [Abstract][Full Text] [Related]
55. Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story.
Drakopoulou E; Anagnou NP; Pappa KI
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35805007
[TBL] [Abstract][Full Text] [Related]
56. Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human.
Chiang CL; Rovelli R; Sarivalasis A; Kandalaft LE
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572778
[TBL] [Abstract][Full Text] [Related]
57. Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness.
Thakur A; Ung J; Tomaszewski EN; Schienschang A; LaBrie TM; Schalk DL; Lum LG
Oncoimmunology; 2021 Jun; 10(1):1930883. PubMed ID: 34123574
[TBL] [Abstract][Full Text] [Related]
58. Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma.
Furubayashi N; Hori Y; Morokuma F; Tomoda T; Negishi T; Inoue T; Kumagai M; Kuroiwa K; Tokuda N; Nakamura M
Mol Clin Oncol; 2021 May; 14(5):91. PubMed ID: 33767860
[TBL] [Abstract][Full Text] [Related]
59. How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression.
Wang Z; Snyder M; Kenison JE; Yang K; Lara B; Lydell E; Bennani K; Novikov O; Federico A; Monti S; Sherr DH
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396563
[TBL] [Abstract][Full Text] [Related]
60. Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension.
Mair KM; Gaw R; MacLean MR
Pulm Circ; 2020; 10(3):2045894020952019. PubMed ID: 32999709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
